Parmjot Bains
About
Detail
Chief Executive Officer
Australia
Résumé
Jobs
verified_user
0% verified
Chief Executive OfficerImpediMedJan 2024 - Current (2 years 6 months)- Gulf Cluster Country ManagerPfizerJun 2022 - Jan 2024 (1 year 8 months)• Led Pfizer commercial business and team across UAE, Kuwait, Qatar, Oman, Bahrain, and Yemen, achieving double-digit growth. • Served as an Executive Committee Member for Pharmag Gulf Cluster, contributing strategic insights and decision-making. • Implemented innovative sales strategies to drive revenue growth and market expansion in the Gulf region.
- Regional Commercial Lead APAC (China, Japan, Korea, ANZ) Hospital BusinessPfizerJun 2021 - Jun 2022 (1 year 1 month)• Led regional marketing teams across China, Japan, South Korea, Australia, and New Zealand for Pfizer's Hospital business. • Developed and executed strategic marketing initiatives to drive brand awareness and market penetration.
- Senior Director Portfolio Development, Developed AsiaPfizerFeb 2019 - Apr 2022 (3 years 3 months)Leading Business Development and Portfolio Optimization activities across Japan, South Korea, Australia and New Zealand
- Non Executive DirectorThe New Zealand Institute for Plant and Food Research LimitedJul 2018 - Sep 2022 (4 years 3 months)
- Senior Director, Global Access ProgramsPfizerApr 2017 - Feb 2019 (1 year 11 months)• Developed innovative healthcare access programs for Governments and NGOs, focusing on oncology medicines access in Sub Saharan Africa in partnership with CHAI and the American Cancer Society. • Led strategic initiatives to enhance global access to healthcare, driving impactful collaborations with key stakeholders. • Achieved measurable success in expanding access to essential medicines, positively impacting patient outcomes and healthcare systems in underserved regions.
- AI Public Health PartnershipsPfizerJul 2015 - Mar 2017 (1 year 9 months)Built access programs for Pfizer’s anti-infectives portfolio
- PCEOPerseis TherapeuticsJul 2008 - May 2012 (3 years 11 months)Breast cancer monoclonal antibody development joint venture between Neuren Pharmaceuticals and the Breast Cancer Research Trust
- Senior Fellow and Advisor, George VenturesThe George Institute for Global HealthMay 2012 - Dec 2014 (2 years 8 months)
- Senior Fellow and Advisor, George VenturesThe George Institute for Global HealthMay 2012 - Dec 2014 (2 years 8 months)
- NChief Executive OfficerNeuren PharmaceuticalsJan 2008 - Jan 2009 (1 year 1 month)
- NChief Operating OfficerNeuren PharmaceuticalsJan 2006 - Jan 2008 (2 years 1 month)Leading global Clinical Trials, Regulatory, CMC, Pharmacovigilance and Quality Operations.
- BD Manager, Acting GM Health and NutritionFonterraJan 2002 - Jan 2004 (2 years 1 month)
- ManagerMcKinsey CompanyJan 1998 - Jan 2002 (4 years 1 month)
- SSnr Paediatric ResidentSydney Childrens HospitalJan 1998
- WInternWorld Health OrganisationJan 1997
- AResident Medical OfficerAuckland HospitalJan 1994 - Jan 1995 (1 year 1 month)
- TMedical ResidentTauranga HospitalNov 1995 - Sep 1996 (11 months)
Education
verified_user
0% verified
- Australian Institute of Company DirectorsAustralian Institute of Company DirectorsJan 2020 - Dec 2020 (1 year)
- University of CambridgeUniversity of CambridgeJan 1996 - Dec 1997 (2 years)
- University of AucklandUniversity of AucklandJan 1989 - Dec 1994 (6 years)
Awards
verified_user
0% verified
- SMost Innovative Company AwardStevie Awards for Women in BusinessOct 2024
- PHealthcare Business Association Rising Star Award 2022Pfizer and HBAMar 2022
- HHealthcare Business Women, Rising Star AwardHBAJan 2022US Healthcare Business Women’s Rising Star Award
- Commonwealth ScholarshipCommonwealthJun 1995
- Prize in Medicine and SurgeryUniversity of AucklandJan 1993